Craig Adam R
Insider CIK 1339498 · SNSS EVP, Development & CMO · XFOR Executive Chairman, Director · CTIC See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc | P Buy | 2026-10-16 | 2026-10-19 | 4,600 | $2.58 | $11.9K | 333,251 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2026-08-12 | 2026-08-13 | 47,436 | $4.44 | $210.6K | 328,651 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2026-08-12 | 2026-08-13 | 47,436 | $4.44 | $210.8K | 328,651 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2025-10-29 | 2025-10-31 | 2,329,154 | — | $0 | 2,329,154 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | P Buy | 2025-10-23 | 2025-10-27 | 86,206 | $2.90 | $250.0K | 376,087 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2025-08-14 | 2025-08-14 | 529,201 | — | $0 | 529,201 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-08-14 | 2025-08-14 | 289,881 | — | $0 | 289,881 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 1,609,873 | — | $0 | 1,609,873 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 450,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 1,200,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 475,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 600,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 470,054 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 2,320,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 800,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 1,115,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 900,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender | 2023-06-26 | 2023-06-26 | 31,470 | $9.10 | $286.4K | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2023-03-14 | 2023-03-16 | 900,000 | — | $0 | 900,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2023-01-24 | 2023-01-26 | 2,117 | — | $0 | 470,054 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2023-01-24 | 2023-01-26 | 83,200 | — | $0 | 472,171 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2023-01-24 | 2023-01-26 | 83,200 | $6.00 | $499.2K | 29,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2023-01-24 | 2023-01-26 | 2,117 | $0.84 | $1.8K | 31,557 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2023-01-24 | 2023-01-26 | 2,117 | $6.01 | $12.7K | 29,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2023-01-24 | 2023-01-26 | 83,200 | $0.84 | $69.9K | 112,640 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2023-01-03 | 2023-01-03 | 84,683 | — | $0 | 555,371 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2023-01-03 | 2023-01-03 | 84,683 | $0.84 | $71.1K | 114,123 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2023-01-03 | 2023-01-03 | 84,683 | $6.01 | $508.9K | 29,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-12-30 | 2023-01-03 | 4,400 | — | $0 | 640,054 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-12-30 | 2023-01-03 | 700 | — | $0 | 644,454 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-12-30 | 2023-01-03 | 12,000 | — | $0 | 645,154 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-12-30 | 2023-01-03 | 12,000 | $0.84 | $10.1K | 41,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-12-30 | 2023-01-03 | 12,000 | $6.00 | $72.0K | 29,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-12-30 | 2023-01-03 | 700 | $0.84 | $588 | 30,140 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-12-30 | 2023-01-03 | 700 | $6.01 | $4.2K | 29,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-12-30 | 2023-01-03 | 4,400 | $0.84 | $3.7K | 33,840 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-12-30 | 2023-01-03 | 4,400 | $6.01 | $26.4K | 29,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award | 2022-12-30 | 2023-01-03 | 1,579 | $5.11 | $8.1K | 29,440 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-12-29 | 2023-01-03 | 13,800 | — | $0 | 657,154 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-12-29 | 2023-01-03 | 13,800 | $0.84 | $11.6K | 41,661 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-12-29 | 2023-01-03 | 13,800 | $6.00 | $82.8K | 27,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-11-10 | 2022-11-14 | 188,304 | — | $0 | 670,954 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-10 | 2022-11-14 | 16,396 | $6.02 | $98.7K | 36,361 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-10 | 2022-11-14 | 100 | $6.02 | $602 | 52,757 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-10 | 2022-11-14 | 26,700 | $6.01 | $160.5K | 52,857 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-10 | 2022-11-14 | 200 | $6.01 | $1.2K | 79,557 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-10 | 2022-11-14 | 136,408 | $6.00 | $818.4K | 79,757 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-10 | 2022-11-14 | 2,700 | $6.04 | $16.3K | 27,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-10 | 2022-11-14 | 5,800 | $6.03 | $35.0K | 30,561 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-11-10 | 2022-11-14 | 188,304 | $0.84 | $158.2K | 216,165 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-11-09 | 2022-11-14 | 53,996 | — | $0 | 859,258 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-09 | 2022-11-14 | 300 | $6.02 | $1.8K | 27,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-09 | 2022-11-14 | 7,596 | $6.01 | $45.7K | 28,161 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-11-09 | 2022-11-14 | 46,100 | $6.00 | $276.6K | 35,757 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-11-09 | 2022-11-14 | 53,996 | $0.84 | $45.4K | 81,857 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-09-12 | 2022-09-14 | 242,300 | — | $0 | 913,254 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-09-12 | 2022-09-14 | 242,300 | $0.84 | $203.5K | 270,161 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-09-12 | 2022-09-14 | 242,300 | $6.43 | $1.56M | 27,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | P Buy | 2022-08-16 | 2022-08-16 | 5,000 | $5.50 | $27.5K | 27,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-07-06 | 2022-07-06 | 18,223 | — | $0 | 1,155,554 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-07-06 | 2022-07-06 | 18,223 | $0.84 | $15.3K | 41,084 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-07-06 | 2022-07-06 | 18,223 | $6.11 | $111.3K | 22,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-07-05 | 2022-07-06 | 27,000 | — | $0 | 1,173,777 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-07-05 | 2022-07-06 | 27,000 | $0.84 | $22.7K | 49,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-07-05 | 2022-07-06 | 27,000 | $6.00 | $162.0K | 22,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-07-01 | 2022-07-06 | 27,000 | — | $0 | 1,200,777 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-07-01 | 2022-07-06 | 27,000 | $0.84 | $22.7K | 49,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-07-01 | 2022-07-06 | 27,000 | $6.00 | $162.0K | 22,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award | 2022-06-30 | 2022-07-06 | 6,183 | $2.12 | $13.1K | 22,861 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-06-03 | 2022-06-03 | 18,223 | — | $0 | 1,227,777 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-06-03 | 2022-06-03 | 18,223 | — | $0 | 1,227,777 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-06-03 | 2022-06-03 | 18,223 | $0.84 | $15.3K | 34,901 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-06-03 | 2022-06-03 | 18,223 | $6.01 | $109.5K | 16,678 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-06-02 | 2022-06-03 | 27,000 | — | $0 | 1,246,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-06-02 | 2022-06-03 | 27,000 | — | $0 | 1,246,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-06-02 | 2022-06-03 | 27,000 | $0.84 | $22.7K | 43,678 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-06-02 | 2022-06-03 | 27,000 | $6.00 | $162.0K | 16,678 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-06-01 | 2022-06-03 | 27,000 | — | $0 | 1,273,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise deriv | 2022-06-01 | 2022-06-03 | 27,000 | — | $0 | 1,273,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-06-01 | 2022-06-03 | 27,000 | $6.00 | $162.0K | 16,678 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | M Exercise | 2022-06-01 | 2022-06-03 | 27,000 | $0.84 | $22.7K | 43,678 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2022-03-09 | 2022-03-11 | 1,115,000 | — | $0 | 1,115,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award | 2021-12-31 | 2022-03-11 | 3,178 | $2.11 | $6.7K | 16,678 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | P Buy | 2021-12-02 | 2021-12-02 | 1,322 | $1.52 | $2.0K | 11,322 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | P Buy | 2021-12-02 | 2021-12-02 | 2,178 | $1.53 | $3.3K | 13,500 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award | 2021-06-30 | 2021-12-02 | 5,000 | $2.13 | $10.7K | 10,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2021-03-10 | 2021-03-12 | 800,000 | — | $0 | 800,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award | 2020-07-01 | 2021-03-12 | 5,000 | $0.98 | $4.9K | 5,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2020-03-11 | 2020-03-13 | 2,320,000 | — | $0 | 2,320,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2019-05-16 | 2019-05-20 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2018-09-18 | 2018-09-20 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2018-05-16 | 2018-05-17 | 475,000 | — | $0 | 475,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2017-09-29 | 2017-10-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2017-03-20 | 2017-03-21 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | F Tax w/h | 2015-02-27 | 2015-03-02 | 8,302 | $2.22 | $18.4K | 23,452 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-02 | 19,031 | — | $0 | 31,754 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2014-10-31 | 2014-11-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-27 | 2014-08-29 | 2,554 | $8.00 | $20.4K | 12,723 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2013-02-28 | 2013-03-01 | 125,000 | — | $0 | 125,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award | 2013-02-28 | 2013-03-01 | 7,662 | — | $0 | 10,257 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2012-02-29 | 2012-03-02 | 600,000 | — | $0 | 600,000 | SEC↗ |